Abstract
Noninfectious pulmonary complications of hematopoietic stem cell transplant are currently
more prevalent than infectious complications. Unfortunately, the pathophysiology basis
is not completely understood. However, there is a string association with graft-versus-host
disease for many of them. Therefore, an important component of their pathophysiology
is likely an allo-immune response. There is much research that needs to be conducted
to improve the less than optimal outcomes for these disorders.
Keywords
Hematopoietic cell transplant - pulmonary complications - graft versus host disease
